{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:52:16Z","timestamp":1791298336404,"version":"4.1.0"},"reference-count":263,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Autonomous Governments of Madrid and Catalonia","award":["2014SGR441"],"award-info":[{"award-number":["2014SGR441"]}]},{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS)"},{"name":"7th Framework Program of the European Union and Foundations"},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Avina Foundation"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.neubiorev.2015.05.014","type":"journal-article","created":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T16:14:59Z","timestamp":1434471299000},"page":"612-626","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":174,"special_numbering":"C","title":["Inflammation in schizophrenia: A question of balance"],"prefix":"10.1016","volume":"55","author":[{"given":"Juan C.","family":"Leza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"Garc\u00eda-Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Bioque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso","family":"Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Parellada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2015.05.014_bib0005","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.schres.2011.11.002","article-title":"SNP-based analysis of neuroactive ligand\u2013receptor interaction pathways implicates PGE2 as a novel mediator of antipsychotic treatment response: data from the CATIE study","volume":"135","author":"Adkins","year":"2012","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2015.05.014_bib0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.schres.2006.11.016","article-title":"Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial","volume":"90","author":"Akhondzadeh","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pnpbp.2004.10.014","article-title":"Association between Ala\u20139Val polymorphism of Mn-SOD gene and schizophrenia","volume":"29","author":"Akyol","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib0020","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbr.2012.03.006","article-title":"Involvement of NMDA receptors in the beneficial effects of pioglitazone on scopolamine-induced memory impairment in mice","volume":"231","author":"Almasi-Nasrabadi","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pnpbp.2012.07.016","article-title":"Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways","volume":"42","author":"Anderson","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0030","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/archgenpsychiatry.2010.22","article-title":"Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder","volume":"67","author":"Andreazza","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib0035","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/oxfordjournals.schbul.a006888","article-title":"At issue: stress, hippocampal neuronal turnover, and neuropsychiatric disorders","volume":"27","author":"Arango","year":"2001","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1001\/archgenpsychiatry.2011.150","article-title":"Progressive brain changes in children and adolescents with first-episode psychosis","volume":"69","author":"Arango","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.neubiorev.2015.05.014_bib0045","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.biopsych.2006.12.021","article-title":"Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia","volume":"62","author":"Arion","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.neubiorev.2015.05.014_bib0050","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.clinph.2013.05.021","article-title":"Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia","volume":"124","author":"Ballesteros","year":"2013","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1405","doi-asserted-by":"crossref","first-page":"6761","DOI":"10.1038\/ncomms7761","article-title":"Synaptic NMDA receptor activity is coupled to the transcriptional control of the glutathione system","volume":"6","author":"Baxter","year":"2015","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.05.014_bib0055","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/schbul\/sbt065","article-title":"Life events and psychosis: a review and meta-analysis","volume":"39","author":"Beards","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0065","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1126\/science.1148045","article-title":"Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase","volume":"318","author":"Behrens","year":"2007","journal-title":"Science"},{"issue":"51","key":"10.1016\/j.neubiorev.2015.05.014_bib0060","doi-asserted-by":"crossref","first-page":"13957","DOI":"10.1523\/JNEUROSCI.4457-08.2008","article-title":"Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia","volume":"28","author":"Behrens","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0070","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nn.2447","article-title":"Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes","volume":"13","author":"Belforte","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"12","key":"10.1016\/j.neubiorev.2015.05.014_bib0075","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/00048670802512073","article-title":"Stress and anxiety in schizophrenia and depression: glucocorticoids, corticotropin-releasing hormone and synapse regression","volume":"42","author":"Bennett","year":"2008","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.neubiorev.2015.05.014_bib0080","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1176\/appi.ajp.2011.11030516","article-title":"Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study","volume":"168","author":"Benros","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0085","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00702-009-0319-5","article-title":"The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia","volume":"116","author":"Ben-Shachar","year":"2009","journal-title":"J. Neural Transm."},{"issue":"12","key":"10.1016\/j.neubiorev.2015.05.014_bib0090","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.4088\/JCP.v68n1206","article-title":"Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial","volume":"68","author":"Berger","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2015.05.014_bib0095","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","article-title":"N-acetyl cysteine as a glutathione precursor for schizophrenia \u2013 a double-blind, randomized, placebo-controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/1741-7015-11-200","article-title":"So depression is an inflammatory disease, but where does the inflammation come from?","volume":"11","author":"Berk","year":"2013","journal-title":"BMC Med."},{"issue":"13","key":"10.1016\/j.neubiorev.2015.05.014_bib0105","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/npp.2013.165","article-title":"Peripheral endocannabinoid system dysregulation in first-episode psychosis","volume":"38","author":"Bioque","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib0110","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","article-title":"Oxidative stress in schizophrenia: an integrated approach","volume":"35","author":"Bitanihirwe","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"11","key":"10.1016\/j.neubiorev.2015.05.014_bib0115","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jpsychires.2012.08.016","article-title":"Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse","volume":"46","author":"Borovcanin","year":"2012","journal-title":"J. Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.neubiorev.2015.05.014_bib0120","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0959-4388(00)00251-8","article-title":"Neuronal plasticity and cellular immunity: shared molecular mechanisms","volume":"11","author":"Boulanger","year":"2001","journal-title":"Curr. Opin. Neurobiol."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib0125","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jad.2008.12.001","article-title":"Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder","volume":"116","author":"Brietzke","year":"2009","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.neubiorev.2015.05.014_bib0130","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/dneu.22024","article-title":"Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism","volume":"72","author":"Brown","year":"2012","journal-title":"Dev. Neurobiol."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1176\/appi.ajp.2009.09030361","article-title":"Prenatal infection and schizophrenia: a review of epidemiologic and translational studies","volume":"167","author":"Brown","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0140","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1086\/420774","article-title":"Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22","volume":"74","author":"Brzustowicz","year":"2004","journal-title":"Am. J. Hum. Genet."},{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2015.05.014_bib0145","first-page":"1","article-title":"Brain derived neurotropic factor in first-episode psychosis","volume":"91","author":"Buckley","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0150","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1016\/j.cellsig.2013.08.007","article-title":"Redox activation of Nrf2 & NF-kappaB: a double end sword?","volume":"25","author":"Buelna-Chontal","year":"2013","journal-title":"Cell Signal."},{"issue":"8","key":"10.1016\/j.neubiorev.2015.05.014_bib0155","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.bbi.2012.08.005","article-title":"Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations?","volume":"26","author":"Busse","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0160","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.biopsych.2012.09.020","article-title":"Early-life insults impair parvalbumin interneurons via oxidative stress: reversal by N-acetylcysteine","volume":"73","author":"Cabungcal","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"22","key":"10.1016\/j.neubiorev.2015.05.014_bib0165","doi-asserted-by":"crossref","first-page":"9130","DOI":"10.1073\/pnas.1300454110","article-title":"Perineuronal nets protect fast-spiking interneurons against oxidative stress","volume":"110","author":"Cabungcal","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0170","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.pharmthera.2011.01.014","article-title":"Immune system to brain signaling: neuropsychopharmacological implications","volume":"130","author":"Capuron","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0175","doi-asserted-by":"crossref","first-page":"e29341","DOI":"10.1371\/journal.pone.0029341","article-title":"Glutathione precursor N-acetyl-cysteine modulates EEG synchronization in schizophrenia patients: a double-blind, randomized, placebo-controlled trial","volume":"7","author":"Carmeli","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0180","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0004867414531078","article-title":"Increased expression of astrocyte markers in schizophrenia: association with neuroinflammation","volume":"48","author":"Catts","year":"2014","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0185","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.2174\/138161208785740018","article-title":"The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases","volume":"14","author":"Centonze","year":"2008","journal-title":"Curr. Pharm. Des."},{"issue":"9","key":"10.1016\/j.neubiorev.2015.05.014_bib0190","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/0269881112444941","article-title":"Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment","volume":"26","author":"Chaudhry","year":"2012","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0195","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1471-4159.2011.07410.x","article-title":"Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E(2) concentration in rat brain","volume":"119","author":"Cheon","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0200","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1523\/JNEUROSCI.21-02-00392.2001","article-title":"Three pairs of cysteine residues mediate both redox and Zn2+ modulation of the NMDA receptor","volume":"21","author":"Choi","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0230","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neubiorev.2014.09.004","article-title":"HPA axis response to social stress is attenuated in schizophrenia but normal in depression: evidence from a meta-analysis of existing studies","volume":"47C","author":"Ciufolini","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"5","key":"10.1016\/j.neubiorev.2015.05.014_bib0205","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/sj.mp.4001806","article-title":"A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia","volume":"11","author":"Clark","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0210","first-page":"298","article-title":"Cognition, dopamine and bioactive lipids in schizophrenia","volume":"3","author":"Condray","year":"2011","journal-title":"Front. Biosci."},{"issue":"5","key":"10.1016\/j.neubiorev.2015.05.014_bib0220","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0361-9230(01)00527-5","article-title":"Glial cell abnormalities in major psychiatric disorders: the evidence and implications","volume":"55","author":"Cotter","year":"2001","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib0225","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/mp.2012.6","article-title":"Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia","volume":"18","author":"Coughlin","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2015.05.014_bib0235","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1007\/s00213-005-0117-1","article-title":"Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia","volume":"182","author":"Dakhale","year":"2005","journal-title":"Psychopharmacology (Berlin)"},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib0245","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0952-3278(98)90109-0","article-title":"Increased arachidonic acid induced platelet chemiluminescence indicates cyclooxygenase overactivity in schizophrenic subjects","volume":"58","author":"Das","year":"1998","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0240","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1006\/bbrc.1995.1980","article-title":"Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain","volume":"212","author":"Das","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0250","first-page":"3251","article-title":"Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease","volume":"82","author":"De Leon","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib0260","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/15622970701361263","article-title":"Isoprostenes as indicators of oxidative stress in schizophrenia","volume":"10","author":"Dietrich-Muszalska","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0265","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1046\/j.1460-9568.2000.00229.x","article-title":"Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo","volume":"12","author":"Do","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0270","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.conb.2009.05.001","article-title":"Redox dysregulation, neurodevelopment, and schizophrenia","volume":"19","author":"Do","year":"2009","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0275","first-page":"S2","article-title":"Receptor for Advanced Glycation End-product (RAGE) as linking mechanism between neuroinflammation and oxidative stress","volume":"41","author":"Do","year":"2015","journal-title":"Schizophr. Bull."},{"issue":"11","key":"10.1016\/j.neubiorev.2015.05.014_bib0280","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2967\/jnumed.109.066647","article-title":"Neuroinflammation in schizophrenia-related psychosis: a PET study","volume":"50","author":"Doorduin","year":"2009","journal-title":"J. Nucl. Med."},{"issue":"5","key":"10.1016\/j.neubiorev.2015.05.014_bib1420","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib0255","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1586\/ern.09.144","article-title":"The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder","volume":"10","author":"Drexhage","year":"2010","journal-title":"Expert Rev. Neurother."},{"issue":"10","key":"10.1016\/j.neubiorev.2015.05.014_bib0285","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1017\/S1461145710000799","article-title":"Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistically treated patients","volume":"13","author":"Drexhage","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.neubiorev.2015.05.014_bib0290","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.eurpsy.2004.06.020","article-title":"Neurotrophic factors and the pathophysiology of schizophrenic psychoses","volume":"19","author":"Durany","year":"2004","journal-title":"Eur. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib0295","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/YCO.0000000000000054","article-title":"Oxidative stress and schizophrenia: recent breakthroughs from an old story","volume":"27","author":"Emiliani","year":"2014","journal-title":"Curr. Opin. Psychiatry"},{"issue":"9","key":"10.1016\/j.neubiorev.2015.05.014_bib0300","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1176\/appi.ajp.159.9.1596","article-title":"Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia","volume":"159","author":"Emsley","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib0305","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.schres.2006.03.023","article-title":"The effects of eicosapentaenoic acid in tardive dyskinesia: a randomized, placebo-controlled trial","volume":"84","author":"Emsley","year":"2006","journal-title":"Schizophr. Res."},{"issue":"1\u20132","key":"10.1016\/j.neubiorev.2015.05.014_bib0310","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.physbeh.2007.05.025","article-title":"The kynurenic acid hypothesis of schizophrenia","volume":"92","author":"Erhardt","year":"2007","journal-title":"Physiol. Behav."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib0315","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00213-013-3261-z","article-title":"A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia","volume":"231","author":"Farokhnia","year":"2014","journal-title":"Psychopharmacology (Berlin)"},{"issue":"12","key":"10.1016\/j.neubiorev.2015.05.014_bib0320","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1176\/appi.ajp.158.12.2071","article-title":"A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia","volume":"158","author":"Fenton","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0325","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/mp.2012.199","article-title":"Markers of inflammation in the prefrontal cortex of individuals with schizophrenia","volume":"18","author":"Fillman","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0330","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1038\/tp.2014.8","article-title":"Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder","volume":"4","author":"Fillman","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"10","key":"10.1016\/j.neubiorev.2015.05.014_bib0335","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.biopsych.2013.01.001","article-title":"Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia","volume":"73","author":"Fineberg","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2015.05.014_bib0340","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.biopsych.2013.03.018","article-title":"Meta-analysis of oxidative stress in schizophrenia","volume":"74","author":"Flatow","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0345","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/schbul\/sbu053","article-title":"Impaired metabolic reactivity to oxidative stress in early psychosis patients","volume":"40","author":"Fournier","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2015.05.014_bib0350","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.schres.2012.01.040","article-title":"Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study","volume":"137","author":"Fraguas","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0355","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pnpbp.2012.12.013","article-title":"Is there an association between peripheral immune markers and structural\/functional neuroimaging findings?","volume":"48","author":"Frodl","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2015.05.014_bib0360","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.schres.2006.11.020","article-title":"Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder","volume":"90","author":"Gallagher","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0365","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1742-2094-8-151","article-title":"Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression","volume":"8","author":"G\u00e1rate","year":"2011","journal-title":"J. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib0370","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.biopsych.2012.07.005","article-title":"Stress-induced neuroinflammation: role of the Toll-like receptor-4 pathway","volume":"73","author":"G\u00e1rate","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0375","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbi.2012.07.008","article-title":"Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development","volume":"31","author":"Garay","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.neubiorev.2015.05.014_bib0395","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/sj.npp.1301252","article-title":"Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats","volume":"32","author":"Garc\u00eda-Bueno","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.neubiorev.2015.05.014_bib0390","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.neubiorev.2008.04.001","article-title":"Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms","volume":"32","author":"Garc\u00eda-Bueno","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"10","key":"10.1016\/j.neubiorev.2015.05.014_bib0400","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1017\/S1461145710000970","article-title":"Is there a role for the nuclear receptor PPAR\u03b3 in neuropsychiatric diseases?","volume":"13","author":"Garc\u00eda-Bueno","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0380","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/schbul\/sbt001","article-title":"Pro-\/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia","volume":"40","author":"Garc\u00eda-Bueno","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0385","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu037","article-title":"Pro\/anti-inflammatory dysregulation in early psychosis: results from a 6-month follow-up study","volume":"18","author":"Garc\u00eda-Bueno","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0405","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.psychres.2011.08.014","article-title":"Inflammatory markers in antipsychotic-naive patients with nonaffective psychosis and deficit vs. nondeficit features","volume":"198","author":"Garcia-Rizo","year":"2012","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib0410","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpsychires.2013.09.017","article-title":"Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-na\u00efve first-episode schizophrenia patients","volume":"48","author":"Gass\u00f3","year":"2014","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib0415","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/S1461145710000805","article-title":"Decreased levels of glutathione, the major brain antioxidant, in postmortem prefrontal cortex from patients with psychiatric disorders","volume":"14","author":"Gawryluk","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"8","key":"10.1016\/j.neubiorev.2015.05.014_bib0420","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3109\/10715762.2011.574290","article-title":"Antioxidant protection: a promising therapeutic intervention in neurodegenerative disease","volume":"45","author":"Ghosh","year":"2011","journal-title":"Free Radic. Res."},{"issue":"6123","key":"10.1016\/j.neubiorev.2015.05.014_bib0425","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1126\/science.1228261","article-title":"Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice","volume":"339","author":"Giovanoli","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0430","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.psychres.2010.10.008","article-title":"Genetic polymorphisms of glutathione S-transferases GSTM1, GSTT1, GSTP1 and GSTA1 as risk factors for schizophrenia","volume":"187","author":"Gravina","year":"2011","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0435","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000070012","article-title":"Decreased production of reactive oxygen species by blood monocytes caused by clozapine correlates with EEG slowing in schizophrenic patients","volume":"47","author":"Gross","year":"2003","journal-title":"Neuropsychobiology"},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib0440","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.cell.2013.06.049","article-title":"Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network","volume":"154","author":"Gulsuner","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0450","doi-asserted-by":"crossref","first-page":"16621","DOI":"10.1073\/pnas.0706778104","article-title":"Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence","volume":"104","author":"Gysin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0445","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1089\/ars.2010.3463","article-title":"Genetic dysregulation of glutathione synthesis predicts alteration of plasma thiol redox status in schizophrenia","volume":"15","author":"Gysin","year":"2011","journal-title":"Antioxid. Redox Signal."},{"issue":"5 Suppl.","key":"10.1016\/j.neubiorev.2015.05.014_bib0455","doi-asserted-by":"crossref","first-page":"715S","DOI":"10.1093\/ajcn\/57.5.715S","article-title":"Lipid peroxidation: its mechanism, measurement, and significance","volume":"57","author":"Halliwell","year":"1993","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0460","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2350-6-7","article-title":"Theories of schizophrenia: a genetic-inflammatory-vascular synthesis","volume":"6","author":"Hanson","year":"2005","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0465","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrn2911","article-title":"Synaptic versus extrasynaptic NMDA receptor signaling: implications for neurodegenerative disorders","volume":"11","author":"Hardingham","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"issue":"10","key":"10.1016\/j.neubiorev.2015.05.014_bib0470","doi-asserted-by":"crossref","first-page":"e46368","DOI":"10.1371\/journal.pone.0046368","article-title":"Comparison of peripheral and central schizophrenia biomarker profiles","volume":"7","author":"Harris","year":"2012","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.neubiorev.2015.05.014_bib0475","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1038\/npp.2011.78","article-title":"Variants of the RELA gene are associated with schizophrenia and their startle responses","volume":"36","author":"Hashimoto","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.neubiorev.2015.05.014_bib0480","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1093\/schbul\/sbu052","article-title":"Inflammatory molecular signature associated with infectious agents in psychosis","volume":"40","author":"Hayes","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0485","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/7854_2010_43","article-title":"Hippocampal pathology in schizophrenia","volume":"4","author":"Heckers","year":"2010","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0490","first-page":"1","article-title":"Identification of a molecular profile associated with immune status in first onset schizophrenia patients","author":"Herberth","year":"2013","journal-title":"Clin. Schizophr. Relat. Psychoses."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0495","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.mp.4000789","article-title":"Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia","volume":"6","author":"Herken","year":"2011","journal-title":"Mol. Psychiatry"},{"issue":"4 Suppl.","key":"10.1016\/j.neubiorev.2015.05.014_bib0500","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.5694\/j.1326-5377.2009.tb02369.x","article-title":"Are common childhood or adolescent infections risk factors for schizophrenia and other psychotic disorders?","volume":"190","author":"Hickie","year":"2009","journal-title":"Med. J. Aust."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib0505","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1254\/jphs.12R15CP","article-title":"Behavioral phenotypes in schizophrenic animal models with multiple combinations of genetic and environmental factors","volume":"121","author":"Hida","year":"2013","journal-title":"J. Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.neubiorev.2015.05.014_bib0510","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2174\/0929867003374282","article-title":"COX-2 in brain and spinal cord implications for therapeutic use","volume":"7","author":"Hoffmann","year":"2000","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib0515","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1523\/JNEUROSCI.2331-12.2013","article-title":"Prenatal stress induces schizophrenia-like alterations of serotonin 2A and metabotropic glutamate 2 receptors in the adult offspring: role of maternal immune system","volume":"33","author":"Holloway","year":"2013","journal-title":"J. Neurosci."},{"issue":"8018","key":"10.1016\/j.neubiorev.2015.05.014_bib0520","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(77)92228-0","article-title":"Schizophrenia as a prostaglandin deficiency disease","volume":"1","author":"Horrobin","year":"1977","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib0525","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.biopsych.2014.01.001","article-title":"Schizophrenia as a disorder of molecular pathways","volume":"77","author":"Horv\u00e1th","year":"2015","journal-title":"Biol. Psychiatry"},{"issue":"7321","key":"10.1016\/j.neubiorev.2015.05.014_bib0530","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature09552","article-title":"Rethinking schizophrenia","volume":"468","author":"Insel","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib0535","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.yco.0000218603.25346.8f","article-title":"Apoptosis in schizophrenia: pathophysiologic and therapeutic considerations","volume":"19","author":"Jarskog","year":"2006","journal-title":"Curr. Opin. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2015.05.014_bib0540","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.schres.2011.11.001","article-title":"Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia","volume":"136","author":"Javitt","year":"2012","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0545","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0021-9150(94)90046-9","article-title":"Lipid peroxidation and homocysteine induced toxicity","volume":"105","author":"Jones","year":"1994","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib0550","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF01255817","article-title":"Elevated plasma prostaglandin E2 levels in schizophrenia","volume":"77","author":"Kaiya","year":"1989","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0555","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/mp.2012.120","article-title":"Genome-wide profiling of multiple histone methylations in olfactory cells: further implications for cellular susceptibility to oxidative stress in schizophrenia","volume":"18","author":"Kano","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"12","key":"10.1016\/j.neubiorev.2015.05.014_bib0560","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/mp.2012.105","article-title":"Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?","volume":"17","author":"Kapur","year":"2012","journal-title":"Mol. Psychiatry"},{"issue":"7","key":"10.1016\/j.neubiorev.2015.05.014_bib0565","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.biopsych.2003.12.012","article-title":"Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study","volume":"55","author":"Karry","year":"2004","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0570","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1471-4159.2008.05435.x","article-title":"Inhibitory effects of aripiprazole on interferon-gamma-induced microglial activation via intracellular Ca2+ regulation in vitro","volume":"106","author":"Kato","year":"2008","journal-title":"J. Neurochem."},{"issue":"2\u20133","key":"10.1016\/j.neubiorev.2015.05.014_bib0575","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.schres.2011.03.019","article-title":"Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate (PMA)-stimulated microglia in vitro: implication for antioxidative psychotropic actions via microglia","volume":"129","author":"Kato","year":"2011","journal-title":"Schizophr. Res."},{"issue":"10","key":"10.1016\/j.neubiorev.2015.05.014_bib0580","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","article-title":"Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study","volume":"71","author":"Khandaker","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib0600","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0920-9964(99)00171-1","article-title":"Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics","volume":"44","author":"Kim","year":"2000","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2015.05.014_bib0585","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","article-title":"Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder","volume":"104","author":"Kim","year":"2007","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0590","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/JCP.0b013e31816777f7","article-title":"A preliminary investigation of alpha-lipoic acid treatment of antipsychotic drug-induced weight gain in patients with schizophrenia","volume":"28","author":"Kim","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib0595","first-page":"130155","article-title":"Oxidation and nitration in dopaminergic areas of the prefrontal cortex from patients with bipolar disorder and schizophrenia","volume":"39","author":"Kim","year":"2014","journal-title":"J. Psychiatry Neurosci."},{"issue":"6","key":"10.1016\/j.neubiorev.2015.05.014_bib0605","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/schbul\/sbt141","article-title":"Inflammation and schizophrenia","volume":"39","author":"Kirkpatrick","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0610","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bbr.2011.10.020","article-title":"Behavioral phenotyping of glutathione-deficient mice: relevance to schizophrenia and bipolar disorder","volume":"226","author":"Kulak","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"Suppl. 1","key":"10.1016\/j.neubiorev.2015.05.014_bib0615","first-page":"73","article-title":"Immune activation, steroid resistancy and bipolar disorder","volume":"4","author":"Kupka","year":"2012","journal-title":"Bipolar Disord."},{"issue":"5","key":"10.1016\/j.neubiorev.2015.05.014_bib0620","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4088\/JCP.09m05117yel","article-title":"Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial","volume":"71","author":"Laan","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0625","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neuron.2013.04.005","article-title":"Innate immunity in the CNS: redefining the relationship between the CNS and its environment","volume":"78","author":"Lampron","year":"2013","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.neubiorev.2015.05.014_bib0630","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0635","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/sj.npp.1301624","article-title":"Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients","volume":"33","author":"Lavoie","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0640","doi-asserted-by":"crossref","first-page":"e22875","DOI":"10.1371\/journal.pone.0022875","article-title":"Altered glycogen metabolism in cultured astrocytes from mice with chronic glutathione deficit; relevance for neuroenergetics in schizophrenia","volume":"6","author":"Lavoie","year":"2011","journal-title":"PLoS ONE"},{"issue":"22","key":"10.1016\/j.neubiorev.2015.05.014_bib0645","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)","volume":"270","author":"Lehmann","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0650","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4088\/JCP.08m04666yel","article-title":"A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia","volume":"71","author":"Levkovitz","year":"2010","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.neubiorev.2015.05.014_bib0660","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/nm1478","article-title":"Pathophysiologically based treatment interventions in schizophrenia","volume":"12","author":"Lewis","year":"2006","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib0655","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tins.2011.10.004","article-title":"Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia","volume":"35","author":"Lewis","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0665","doi-asserted-by":"crossref","first-page":"9936","DOI":"10.1073\/pnas.0502552102","article-title":"Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib0670","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/schbul\/sbq086","article-title":"Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia","volume":"38","author":"Linderholm","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2015.05.014_bib0675","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2013.09.007","article-title":"Effects of maternal immune activation on adult neurogenesis in the subventricular zone-olfactory bulb pathway and olfactory discrimination","volume":"151","author":"Liu","year":"2013","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib0680","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1017\/S1461145711001775","article-title":"Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation","volume":"16","author":"MacDowell","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0685","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0022-3956(94)00049-W","article-title":"Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers","volume":"29","author":"Maes","year":"1995","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0690","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1523\/JNEUROSCI.15-09-06239.1995","article-title":"Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death","volume":"15","author":"Mark","year":"1995","journal-title":"J. Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2015.05.014_bib0700","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.schres.2011.01.018","article-title":"The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia","volume":"128","author":"Mart\u00ednez-Gras","year":"2011","journal-title":"Schizophr. Res."},{"issue":"9","key":"10.1016\/j.neubiorev.2015.05.014_bib0705","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1176\/ajp.152.9.1291","article-title":"Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status","volume":"152","author":"McAllister","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0710","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.mehy.2005.06.022","article-title":"Impaired neuronal glucose uptake in pathogenesis of schizophrenia \u2013 can GLUT 1 and GLUT-3 deficits explain imaging, postmortem and pharmacological findings?","volume":"65","author":"McDermott","year":"2005","journal-title":"Med. Hypotheses"},{"issue":"10","key":"10.1016\/j.neubiorev.2015.05.014_bib0715","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1517\/14656566.7.10.1305","article-title":"Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities","volume":"7","author":"McIntyre","year":"2006","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0720","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1038\/tp.2011.37","article-title":"Enhanced peripheral toll-like receptor responses in psychosis: further evidence of a pro-inflammatory phenotype","volume":"1","author":"McKernan","year":"2011","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0725","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/schbul\/sbn022","article-title":"A review of the fetal brain cytokine imbalance hypothesis of schizophrenia","volume":"35","author":"Meyer","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib0730","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pharmthera.2011.06.003","article-title":"Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative\/cognitive symptoms and beyond","volume":"132","author":"Meyer","year":"2011","journal-title":"Pharmacol. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.neubiorev.2015.05.014_bib0735","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000068019","article-title":"Severe tardive dyskinesia in affective disorders: treatment with vitamin E and C","volume":"46","author":"Michael","year":"2002","journal-title":"Neuropsychobiology"},{"issue":"10","key":"10.1016\/j.neubiorev.2015.05.014_bib0740","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/dneu.22044","article-title":"Immune system gene dysregulation in autism and schizophrenia","volume":"72","author":"Michel","year":"2012","journal-title":"Dev. Neurobiol."},{"issue":"7","key":"10.1016\/j.neubiorev.2015.05.014_bib0745","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1523\/JNEUROSCI.22-07-02718.2002","article-title":"Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia","volume":"22","author":"Middleton","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0750","unstructured":"Miller, B. An Open-Label Trial of Tocilizumab in Schizophrenia. Clinicaltrials.gov: NCT01696929."},{"issue":"7","key":"10.1016\/j.neubiorev.2015.05.014_bib0755","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0760","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pnpbp.2012.03.010","article-title":"Prenatal inflammation and neurodevelopment in schizophrenia: a review of human studies","volume":"42","author":"Miller","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0765","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.biopsych.2012.09.007","article-title":"Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects","volume":"73","author":"Miller","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib0775","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jaac.2013.11.013","article-title":"Inflammation in children and adolescents with neuropsychiatric disorders: a systematic review","volume":"53","author":"Mitchell","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0770","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/schbul\/sbr148","article-title":"Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0780","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fpsyt.2011.00015","article-title":"Possible effects of synaptic imbalances on oligodendrocyte\u2013axonic interactions in schizophrenia: a hypothetical model","volume":"2","author":"Mitterauer","year":"2011","journal-title":"Front. Psychiatry"},{"issue":"12","key":"10.1016\/j.neubiorev.2015.05.014_bib0785","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.4088\/JCP.10m06745","article-title":"Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume","volume":"72","author":"Mondelli","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0790","article-title":"Glutathione deficit impairs myelin maturation: relevance for white matter integrity in schizophrenia patients","author":"Monin","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0795","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pnpbp.2011.12.002","article-title":"Neuroinflammation in schizophrenia especially focused on the role of microglia","volume":"42","author":"Monji","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2015.05.014_bib0810","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1176\/appi.ajp.159.6.1029","article-title":"Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia","volume":"159","author":"M\u00fcller","year":"2002","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2015.05.014_bib0800","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.schres.2010.04.015","article-title":"Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment","volume":"121","author":"M\u00fcller","year":"2010","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib0815","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.psychres.2011.12.049","article-title":"Impaired monocyte activation in schizophrenia","volume":"198","author":"M\u00fcller","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0820","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/B978-0-12-398314-5.00003-9","article-title":"Inflammation in schizophrenia","volume":"88","author":"M\u00fcller","year":"2012","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0805","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pnpbp.2012.11.008","article-title":"Anti-inflammatory treatment in schizophrenia","volume":"42","author":"M\u00fcller","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0825","article-title":"Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis","author":"Myint","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0830","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1742-2094-10-43","article-title":"Neuroinflammation and psychiatric illness","volume":"10","author":"Najjar","year":"2013","journal-title":"J. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.neubiorev.2015.05.014_bib0835","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri3423","article-title":"Beyond oxidative stress: an immunologist's guide to reactive oxygen species","volume":"13","author":"Nathan","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0840","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fpsyt.2013.00045","article-title":"BDNF and schizophrenia: from neurodevelopment to neuronal plasticity, learning, and memory","volume":"4","author":"Nieto","year":"2013","journal-title":"Front. Psychiatry"},{"issue":"11","key":"10.1016\/j.neubiorev.2015.05.014_bib0845","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1176\/ajp.156.11.1725","article-title":"Accumulation of macrophages in the CSF of schizophrenic patients during acute psychotic episodes","volume":"156","author":"Nikkila","year":"1999","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.neubiorev.2015.05.014_bib0850","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0920-9964(99)00218-2","article-title":"Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia","volume":"49","author":"Nikkila","year":"2001","journal-title":"Schizophr. Res."},{"issue":"2\u20133","key":"10.1016\/j.neubiorev.2015.05.014_bib0855","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.schres.2005.07.013","article-title":"Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia","volume":"80","author":"Nilsson","year":"2005","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0860","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00019442-200403000-00008","article-title":"Evidence for oxidative DNA damage in the hippocampus of elderly patients with chronic schizophrenia","volume":"12","author":"Nishioka","year":"2004","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2015.05.014_bib0865","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/schbul\/sbt070","article-title":"Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials","volume":"39","author":"Nitta","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"6117","key":"10.1016\/j.neubiorev.2015.05.014_bib0870","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1126\/science.1226931","article-title":"Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids","volume":"339","author":"Niwa","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2015.01.026","article-title":"Effects of depression on the cytokine profile in drug naive first-episode psychosis","author":"Noto","year":"2015","journal-title":"Schizophr. Res."},{"issue":"12","key":"10.1016\/j.neubiorev.2015.05.014_bib0880","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1460-9568.2012.08130.x","article-title":"Cortical interneurons, immune factors and oxidative stress as early targets for schizophrenia","volume":"35","author":"O\u2019Donnell","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0885","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/schbul\/sbu048","article-title":"Oxidative\/nitrosative stress in psychiatric disorders: are we there yet?","volume":"40","author":"O\u2019Donnell","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0890","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.brainres.2010.09.054","article-title":"Maternal immune activation by polyriboinosinic\u2013polyribocytidilic acid injection produces synaptic dysfunction but not neuronal loss in the hippocampus of juvenile rat offspring","volume":"1363","author":"Oh-Nishi","year":"2010","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib0895","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0952-3278(92)90060-V","article-title":"Influences of cyclooxygenase inhibitors on the cataleptic behavior induced by haloperidol in mice","volume":"46","author":"Ono","year":"1992","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gm300","article-title":"Phospholipids and insulin resistance in psychosis: a lipidomics study of twin pairs discordant for schizophrenia","volume":"4","author":"Oresic","year":"2012","journal-title":"Genome Med."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.05.014_bib0905","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.bbi.2012.01.015","article-title":"Maternal immune activation by LPS selectively alters specific gene expression profiles of interneuron migration and oxidative stress in the fetus without triggering a fetal immune response","volume":"26","author":"Oskvig","year":"2012","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.neubiorev.2015.05.014_bib0910","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.biopsych.2005.07.031","article-title":"Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia","volume":"59","author":"Ozawa","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0915","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/schbul\/sbr178","article-title":"Priming of metabolic dysfunctions by prenatal immune activation in mice: relevance to schizophrenia","volume":"39","author":"Pacheco-L\u00f3pez","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib0925","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3956(01)00048-6","article-title":"A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms","volume":"36","author":"Peet","year":"2002","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib0920","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0920-9964(00)00083-9","article-title":"Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia","volume":"49","author":"Peet","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0930","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainresrev.2006.02.002","article-title":"Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders","volume":"52","author":"Phillis","year":"2006","journal-title":"Brain Res. Rev."},{"issue":"8","key":"10.1016\/j.neubiorev.2015.05.014_bib0935","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","article-title":"Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review","volume":"63","author":"Potvin","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.neubiorev.2015.05.014_bib0940","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.mp.4001532","article-title":"Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress","volume":"9","author":"Prabakaran","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0945","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1476-9255-5-14","article-title":"15-deoxy-delta12,14-prostaglandin J2 attenuates endothelial\u2013monocyte interaction: implication for inflammatory diseases","volume":"5","author":"Prasad","year":"2008","journal-title":"J. Inflamm. (Lond.)"},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib0950","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jnen\/59.2.137","article-title":"Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics","volume":"59","author":"Radewicz","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib0955","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"10.1016\/j.neubiorev.2015.05.014_bib0960","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.biopsych.2005.02.024","article-title":"Celecoxib augmentation of continuously ill patients with schizophrenia","volume":"57","author":"Rapaport","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0965","first-page":"S183","article-title":"Celecoxib add-on therapy does not have beneficial antipsychotic effects over risperidone alone in schizophrenia","volume":"29","author":"Rappard","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0970","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0006-8993(00)02212-5","article-title":"Oxidative stress and HNE conjugation of GLUT-3 are increased in the hippocampus of diabetic rats subjected to stress","volume":"862","author":"Reagan","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0980","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/sj.mp.4001779","article-title":"Neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function","volume":"11","author":"Reif","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0975","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/sj.mp.4001791","article-title":"Neural stem cell proliferation is decreased in schizophrenia, but not in depression","volume":"11","author":"Reif","year":"2006","journal-title":"Mol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2015.05.014_bib0985","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.schres.2013.10.040","article-title":"Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: reversal by clozapine","volume":"151","author":"Ribeiro","year":"2013","journal-title":"Schizophr. Res."},{"issue":"9","key":"10.1016\/j.neubiorev.2015.05.014_bib0990","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2146\/ajhp110271","article-title":"Schizophrenia and the immune system: pathophysiology, prevention, and treatment","volume":"69","author":"Richard","year":"2012","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib0995","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbi.2013.07.006","article-title":"Prenatal versus postnatal maternal factors in the development of infection-induced working memory impairments in mice","volume":"33","author":"Richetto","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib1000","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/schbul\/sbs195","article-title":"Prenatal immune activation induces maturation-dependent alterations in the prefrontal GABAergic transcriptome","volume":"40","author":"Richetto","year":"2014","journal-title":"Schizophr. Bull."},{"issue":"10","key":"10.1016\/j.neubiorev.2015.05.014_bib1005","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/ng.2742","article-title":"Genome-wide association analysis identifies 13 new risk loci for schizophrenia","volume":"45","author":"Ripke","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1010","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/mp.2009.53","article-title":"Association of common copy number variants at the glutathione S-transferase genes and rare novel genomic changes with schizophrenia","volume":"15","author":"Rodr\u00edguez-Santiago","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1015","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/ajmg.b.31062","article-title":"Analysis of whole genome biomarker expression in blood and brain","volume":"153B","author":"Rollins","year":"2010","journal-title":"Am. J. Med. Genet. B"},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib1020","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-012-2722-0","article-title":"NMDA receptor involvement in antidepressant-like effect of pioglitazone in the forced swimming test in mice","volume":"223","author":"Salehi-Sadaghiani","year":"2012","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1025","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/schbul\/sbq112","article-title":"Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia","volume":"37","author":"Sathyasaikumar","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1030","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1100\/tsw.2008.140","article-title":"Cytokines and myelination in the central nervous system","volume":"8","author":"Schmitz","year":"2008","journal-title":"Sci. World J."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuron.2013.02.011","article-title":"Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver","volume":"78","author":"Schobel","year":"2013","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.neubiorev.2015.05.014_bib1040","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0006-3223(01)01078-2","article-title":"Increased cortical kynurenate content in schizophrenia","volume":"50","author":"Schwarcz","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4137\/BMI.S4877","article-title":"Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia","volume":"5","author":"Schwarz","year":"2010","journal-title":"Biomark. Insights"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1050","first-page":"41","article-title":"Mediation of inflammation by cyclooxygenase-2","volume":"46","author":"Seibert","year":"1995","journal-title":"Agents Actions Suppl."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib1055","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1001\/jamapsychiatry.2014.2427","article-title":"Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes","volume":"72","author":"Setiawan","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"7256","key":"10.1016\/j.neubiorev.2015.05.014_bib1065","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nature08192","article-title":"Common variants on chromosome 6p22.1 are associated with schizophrenia","volume":"460","author":"Shi","year":"2009","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib1070","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.euroneuro.2004.12.005","article-title":"The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia","volume":"15","author":"Shoval","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1075","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1113\/expphysiol.1997.sp004024","article-title":"Oxidative stress: oxidants and antioxidants","volume":"82","author":"Sies","year":"1997","journal-title":"Exp. Physiol."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.05.014_bib1080","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4088\/JCP.10r06823","article-title":"Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis","volume":"73","author":"Sommer","year":"2011","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2015.05.014_bib1090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.biopsych.2008.10.018","article-title":"The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia","volume":"65","author":"Song","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"6180","key":"10.1016\/j.neubiorev.2015.05.014_bib1095","doi-asserted-by":"crossref","first-page":"1240622","DOI":"10.1126\/science.1240622","article-title":"Interneurons from embryonic development to cell-based therapy","volume":"344","author":"Southwell","year":"2014","journal-title":"Science"},{"issue":"7256","key":"10.1016\/j.neubiorev.2015.05.014_bib1100","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature08186","article-title":"Common variants conferring risk of schizophrenia","volume":"460","author":"Stefansson","year":"2009","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib1110","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00401-006-0090-8","article-title":"Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization","volume":"112","author":"Steiner","year":"2006","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib1105","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpsychires.2006.10.013","article-title":"Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide","volume":"42","author":"Steiner","year":"2008","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1115","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.neuroscience.2005.10.014","article-title":"Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia","volume":"137","author":"Steullet","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1125","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1523\/JNEUROSCI.3857-09.2010","article-title":"Chronic redox dysregulation affects the ventral but not dorsal hippocampus: impairment of parvalbumin neurons, gamma oscillations and related behaviors","volume":"30","author":"Steullet","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1120","article-title":"Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: a \u201ccentral hub\u201d in schizophrenia pathophysiology?","author":"Steullet","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1130","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/0269881106073126","article-title":"Glutamate and dopamine dysregulation in schizophrenia \u2013 a synthesis and selective review","volume":"21","author":"Stone","year":"2007","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib1135","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pnpbp.2008.12.006","article-title":"Atypical antipsychotics suppress production of proinflammatory cytokines and up-regulate interleukin-10 in lipopolysaccharide-treated mice","volume":"33","author":"Sugino","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.neubiorev.2015.05.014_bib1140","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.schres.2008.04.018","article-title":"Association between interleukin-6 receptor polymorphism and patients with schizophrenia","volume":"102","author":"Sun","year":"2008","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib1145","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(01)02449-1","article-title":"Prostaglandin E(2) induces caspase-dependent apoptosis in rat cortical cells","volume":"317","author":"Takadera","year":"2002","journal-title":"Neurosci. Lett."},{"issue":"2\u20133","key":"10.1016\/j.neubiorev.2015.05.014_bib1150","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.schres.2013.07.036","article-title":"Reduced anterior cingulate gray matter volume and thickness in subjects with deficit schizophrenia","volume":"150","author":"Takayanagi","year":"2013","journal-title":"Schizophr. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.neubiorev.2015.05.014_bib1155","first-page":"65","article-title":"Psychiatric emergencies (part II): psychiatric disorders coexisting with organic diseases","volume":"17","author":"Testa","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"7819","key":"10.1016\/j.neubiorev.2015.05.014_bib1160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(73)91952-1","article-title":"Slow and latent viruses in schizophrenia","volume":"2","author":"Torrey","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1165","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1086\/507566","article-title":"Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene","volume":"79","author":"Tosic","year":"2006","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.neubiorev.2015.05.014_bib1170","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4088\/JCP.12r07694","article-title":"Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis","volume":"73","author":"Udina","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"10","key":"10.1016\/j.neubiorev.2015.05.014_bib1415","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00127-014-0934-9","article-title":"Inflammation and psychopathology: what we now know, and what we need to know","volume":"49","author":"Uddin","year":"2014","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib1175","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/15622970903414188","article-title":"Ultrastructural damage of capillaries in the neocortex in schizophrenia","volume":"11","author":"Uranova","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib1195","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"9","key":"10.1016\/j.neubiorev.2015.05.014_bib1180","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.biopsych.2008.04.025","article-title":"Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study","volume":"64","author":"van Berckel","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"9690","key":"10.1016\/j.neubiorev.2015.05.014_bib1185","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(09)60995-8","volume":"374","author":"van Os","year":"2009","journal-title":"Schizophr. Lancet"},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib1190","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/schbul\/sbq062","article-title":"Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis","volume":"38","author":"van Venrooij","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1200","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1038\/tp.2012.116","article-title":"Progressive loss of cortical gray matter in schizophrenia: a meta-analysis and meta-regression of longitudinal MRI studies","volume":"2","author":"Vita","year":"2012","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"10.1016\/j.neubiorev.2015.05.014_bib1205","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1523\/JNEUROSCI.5408-09.2010","article-title":"A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia","volume":"30","author":"Vuillermot","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1210","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev.clinpsy.4.022007.141248","article-title":"Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia","volume":"4","author":"Walker","year":"2008","journal-title":"Annu. Rev. Clin. Psychol."},{"issue":"6","key":"10.1016\/j.neubiorev.2015.05.014_bib1215","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.euroneuro.2013.12.005","article-title":"Evidence that aetiological risk factors for psychiatric disorders cause distinct patterns of cognitive deficits","volume":"24","author":"Wallace","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.neubiorev.2015.05.014_bib1220","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1399-5618.2009.00717.x","article-title":"Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia","volume":"11","author":"Wang","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1225","first-page":"S314","article-title":"A randomized trial administering aspirin, minocycline or pramipexole vs placebo as add-on to antipsychotics in patients with schizophrenia or schizoaffecive disorder","volume":"38","author":"Weiser","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib1230","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.schres.2012.02.014","article-title":"A randomized controlled trial of allopurinol vs. placebo added on to antipsychotics in patients with schizophrenia or schizoaffective disorder","volume":"138","author":"Weiser","year":"2012","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib1235","first-page":"81","article-title":"Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics","volume":"43","author":"Wierzba-Bobrowicz","year":"2005","journal-title":"Folia Neuropathol."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib1240","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.bbr.2011.07.033","article-title":"Behavioural deficits associated with maternal immune activation in the rat model of schizophrenia","volume":"225","author":"Wolff","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1245","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archgenpsychiatry.2011.71","article-title":"Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes","volume":"68","author":"Wonodi","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1250","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pnpbp.2013.02.015","article-title":"Free radicals, antioxidant defense systems, and schizophrenia","volume":"46","author":"Wu","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1265","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1089\/ars.2010.3603","article-title":"Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view","volume":"15","author":"Yao","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1270","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0074-7742(04)59012-8","article-title":"Membrane phospholipids and cytokine interaction in schizophrenia","volume":"59","author":"Yao","year":"2004","journal-title":"Int. Rev. Neurobiol."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.05.014_bib1260","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/oxfordjournals.schbul.a007142","article-title":"Increased nitric oxide radicals in postmortem brain from patients with schizophrenia","volume":"30","author":"Yao","year":"2004","journal-title":"Schizophr. Bull."},{"issue":"1\u20132","key":"10.1016\/j.neubiorev.2015.05.014_bib1255","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1155\/2006\/248387","article-title":"Altered glutathione redox state in schizophrenia","volume":"22","author":"Yao","year":"2006","journal-title":"Dis. Markers"},{"issue":"2\u20133","key":"10.1016\/j.neubiorev.2015.05.014_bib1275","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.psychres.2012.05.020","article-title":"Rosiglitazone and cognitive function in clozapine-treated patients with schizophrenia: a pilot study","volume":"200","author":"Yi","year":"2012","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.neubiorev.2015.05.014_bib1280","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.pnpbp.2004.05.018","article-title":"Neuronal expression of cyclooxygenase-2, a pro-inflammatory protein, in the hippocampus of patients with schizophrenia","volume":"28","author":"Yokota","year":"2004","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib1285","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1128\/CMR.8.1.131","article-title":"Viruses, schizophrenia, and bipolar disorder","volume":"8","author":"Yolken","year":"1995","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1290","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1046\/j.1471-4159.2000.0741000.x","article-title":"Glucocorticoids exacerbate the deleterious effects of gp120 in hippocampal and cortical explants","volume":"74","author":"Yusim","year":"2000","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neubiorev.2015.05.014_bib1295","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1134\/S0006297913010033","article-title":"Keap1\/Nrf2\/ARE redox-sensitive signaling system as a pharmacological target","volume":"78","author":"Zenkov","year":"2013","journal-title":"Biochemistry (Moscow)"},{"issue":"11","key":"10.1016\/j.neubiorev.2015.05.014_bib1310","doi-asserted-by":"crossref","first-page":"878","DOI":"10.4088\/JCP.v62n1107","article-title":"A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia","volume":"62","author":"Zhang","year":"2001","journal-title":"J. Clin. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2015.05.014_bib1410","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00004714-200304000-00004","article-title":"The effect of risperidone treatment on superoxide dismutase in schizophrenia","volume":"23","author":"Zhang","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2\u20133","key":"10.1016\/j.neubiorev.2015.05.014_bib1305","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.schres.2005.10.011","article-title":"Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics","volume":"81","author":"Zhang","year":"2006","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.neubiorev.2015.05.014_bib1300","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00213-008-1295-4","article-title":"Lower serum cytokine levels in smokers than nonsmokers with chronic schizophrenia on long-term treatment with antipsychotics","volume":"201","author":"Zhang","year":"2008","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neubiorev.2015.05.014_bib1315","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1523\/JNEUROSCI.3648-05.2006","article-title":"Distinct morphological stages of dentate granule neuron maturation in the adult mouse hippocampus","volume":"26","author":"Zhao","year":"2006","journal-title":"J. Neurosci."}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763415001402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763415001402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T14:58:37Z","timestamp":1717945117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763415001402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":263,"alternative-id":["S0149763415001402"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2015.05.014","relation":{},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation in schizophrenia: A question of balance","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2015.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}